You Are Browsing ‘Sectors’ Category

Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start Phase 2b human clinical trial in pancreatic cancer in some time. Before the trial begins, the company has decided to talk about pancreatic cancer to enhance the awareness of people about pancreatic cancer and cutting-edge technology used by the company...

Axcess Canada Inc. president Tim Magill dumped his tablet in favor of the Blackberry Ltd (NASDAQ:BBRY) Passport, and he has a very good reason to justify...

Pandora Media Inc (NYSE:P) recently announced that the cost of its artist royalties summed up to approximately $500 million in past one year. This means...

Symphony Health, a research firm, recently released a report regarding EXPAREL sales and volume for the August estimates. The report stated that the estimate...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) released an educational article that will allow people to know about its technology and its application in pancreatic...

Dialog Semiconductor Plc’s stock price declined 19% after the chipmaker firm reported a cash-and-stock deal to acquire Atmel Corporation (NASDAQ:ATML),...

Frontier Secure, a service arm of Frontier Communications Corp (NASDAQ:FTR) added two new products named as the Nest Protect and Nest Cam to its product...

Senteeko Tea Estate is one of the major operating platform of Plandai Biotechnology Inc (OTCMKTS:PLPL). It is located in South Africa and spreads on as...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to discuss some of its major milestones right before the phase 2b clinical trial in pancreatic cancer...

After recording strong gains in last week, the stock price of Fitbit Inc (NYSE:FIT) declined 0.32% on Monday to start the week mildly in red. The stock...